[1]
«An Open Label Clinical Study Evaluating the Effectiveness of a Cryptolepis sanguinolenta based Herbal Antimalarial Agent», AJBR, libk. 22, zenb. 3, or. 257–262, abe. 2019, Eskuratua: 2026(e)ko apirilaren 11(e)an. [Sarean]. Available at: https://ojshostng.com/index.php/ajbr/article/view/1321